These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30406708)
1. No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis. Kiuchi Z; Ogura M; Sato M; Kamei K; Ishikura K; Abe J; Ito S Scand J Rheumatol; 2019 May; 48(3):246-248. PubMed ID: 30406708 [No Abstract] [Full Text] [Related]
2. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis. Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106 [TBL] [Abstract][Full Text] [Related]
3. Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis. Takakura M; Shimizu M; Yakoyama T; Mizuta M; Yachie A Pediatr Int; 2018 Oct; 60(10):984-985. PubMed ID: 30345698 [No Abstract] [Full Text] [Related]
4. Outcome of PatientsWith Systemic Onset Juvenile Idiopathic Arthritis With Macrophage Activation Syndrome at Onset. Raghuram J; Gornale VK; Rao AP Indian Pediatr; 2021 Jan; 58(1):87. PubMed ID: 33452788 [No Abstract] [Full Text] [Related]
5. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357 [TBL] [Abstract][Full Text] [Related]
6. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Bracaglia C; de Graaf K; Pires Marafon D; Guilhot F; Ferlin W; Prencipe G; Caiello I; Davì S; Schulert G; Ravelli A; Grom AA; de Min C; De Benedetti F Ann Rheum Dis; 2017 Jan; 76(1):166-172. PubMed ID: 27296321 [TBL] [Abstract][Full Text] [Related]
7. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis. Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559 [TBL] [Abstract][Full Text] [Related]
16. 50 Years Ago in TheJournalofPediatrics: Hepatic Dysfunction in Systemic Juvenile Idiopathic Arthritis with Alleviation of Arthritis: The First Description of Macrophage Activation Syndrome? Ashkenazi L; Hashkes PJ J Pediatr; 2021 Jul; 234():64. PubMed ID: 34172168 [No Abstract] [Full Text] [Related]
17. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children. Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176 [TBL] [Abstract][Full Text] [Related]
18. Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series. Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Yachie A Mod Rheumatol; 2017 Sep; 27(5):833-837. PubMed ID: 28094589 [TBL] [Abstract][Full Text] [Related]
19. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis. Juneja M; Jain R; Mishra D Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084 [TBL] [Abstract][Full Text] [Related]
20. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis. Schulert GS; Minoia F; Bohnsack J; Cron RQ; Hashad S; KonÉ-Paut I; Kostik M; Lovell D; Maritsi D; Nigrovic PA; Pal P; Ravelli A; Shimizu M; Stanevicha V; Vastert S; Woerner A; de Benedetti F; Grom AA Arthritis Care Res (Hoboken); 2018 Mar; 70(3):409-419. PubMed ID: 28499329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]